This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
Cardium Therapeutics, Inc., a medical technology company, engages in the development and commercialization of products and devices for cardiovascular and ischemic diseases, wound healing, and tissue repair.View CXM key stats
n.a. - CXM - EQUITY
Reviewed By: TheStreet Ratings on .
Report Summary: TheStreet Ratings team rates n.a. as a
Sell with a ratings score of D-.
Report Snippet: We rate CARDIUM THERAPEUTICS INC (CXM) a SELL. This is driven by a few notable weaknesses, which we believe should have a greater impact than any strengths, and could make it more difficult for investors to achieve positive results compared to most of the stocks we cover. The company's weaknesses can be seen in multiple areas, such as its disappointing return on equity and generally disappointing historical performance in the stock itself.